| Goal: This topic plans through the clinical observation to discuss xiaoqinglong Decoction modified to send Interstitial lung disease (ILD) to clod phlegm-fluid lying latent in the lung, the lung winds the rheumatism anti- card the treatment result, the display Chinese medicine superiority, thus discusses new treatment ILD the standardized Chinese medicine diagnosing and treating plan, by the better instruction clinical practice, improves the IPF patient's survival quality. Treats this sickness from the Chinese medicine aspect, reported that treats an illness must ask in this principle, prevents the mesenchymal lung disease's outbreak, to enhance the clinical curative effect and the foundation treatment mesenchymal lung disease's new method has the significant significance.Method: The selection conforms to the condition outpatient service and cures the area in hospital patient 60 examples, uses the computer to divide into the observation group stochastically (the Chinese medicine treatment group - Xiaoqinglong Decoction modified) and the control group (doctor practicing western medicine treats group - strong pine). Each group of each 30 examples.Finally: In the clinical observation, two group of curative effect result contrast, treatment group total effectiveness is 76.67%,The total effective rate between the two groups (P> 0.05) note the treatment group and control group similar effect。Conclusion:The clinical research indicated that xiaoqinglong Decoction modified regarding has interstitial lung disease (clod phlegm-fluid lying latent in the lung, lung winds rheumatism anti-) the curative effect to be accurate, surpasses the small dosage sugar cortical hormone, especially in improvement clinical symptoms aspect curative effect outstandingly, moreover the non-toxic side effect, the medication simple economy, easy to implement, displayed the Chinese medicine to treat undiagnosed cases's superiority fully, had the research and the development value. |
PDF Full Text Request